Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill expanding Utah’s Right‑to‑Try law beyond terminal diagnoses
Summary
Senators voted 3‑1 to favorably recommend SB 222, which would broaden Utah’s Right to Try statute to allow patients with an “eligible illness” (not only terminal patients) to access investigational treatments that have completed phase 1 trials; sponsors and industry argued it will aid local innovation while lawmakers pressed for safeguards on informed consent and IRB protections.
The Senate Health and Human Services Committee voted to favorably recommend SB 222, a proposal to amend the Utah Right to Try Act by replacing the current terminal‑illness requirement with a broader "eligible illness" standard and expanding allowable dosage formulations for investigational treatments.
Sponsor Senator Wilson told the committee the change would align Utah with other states and make investigational treatments…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
